Animal NDC 86093-2001-1 Exegen Cln3 Miniswine
Pcln3-neo Excised

Exegen Cln3 Miniswine Images

Exegen Cln3 Miniswine Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Exegen Cln3 Miniswine



ExeGen CLN3 miniswine are genetically engineered yucatan miniature swine containing the rDNA construct pCLN3-Neo Excised which exhibit similar phenotypes to human patients with CLN3 disease. These pigs are intended to be used as large animal models of the human disease. We will not be requesting a food use authorization and the carcasses and all materials generated from these animals will be destroyed by incineration.

Product Definition: A specific line of Yucatan miniature pigs (Sus scrofa domesticus), including homozygous offspring resulting from a heterozygous founder, in which the CLN3 gene has been disrupted by the homologous recombination of a single copy of a mutated CLN3-PGK construct for use in biomedical research. The desirable animal will be a homozygote CLN3 Ex7-8del Neo Excised/Ex7-8del Neo Excised miniswine.

Warning: This product is from a genetically engineered animal and may contain an investigational new animal drug. It is for research purposes only and not for use in humans or as food/feed unless authorization has been granted by the US Food and Drug Administration. In case of emergency or release contact Exemplar Genetics at 712-722-2767 or 712-441-3408.


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.